Although significant progress has been made in diabetes treatment in recent years with new technologies and medications, such as insulin pumps and continuous glucose monitoring devices, the treatment of diabetes remains a significant burden for patients because of the need for dynamic blood sugar monitoring and adjustment. This evidence concerns the gene INS and diabetes mellitus.